Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics

被引:52
作者
Mukai, Hidefumi [1 ,2 ]
Ogawa, Koki [1 ]
Kato, Naoya [1 ]
Kawakami, Shigeru [1 ]
机构
[1] Nagasaki Univ, Grad Sch Biomed Sci, Dept Pharmaceut Informat, 1-7-1 Sakamoto, Nagasaki 8528588, Japan
[2] RIKEN Ctr Biosyst Dynam Res, Lab Mol Delivery & Imaging Technol, Chuo Ku, 6-7-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan
关键词
Lipid nanoparticle; Nucleic acid; mRNA; Gene editing; Base editing; Ionizable lipid; Targeting; DNA barcode; Recombination; Positron emission tomography; IN-VIVO; TARGETED DELIVERY; MANNOSE RECEPTOR; DRUG; DNA; SIRNA; EXPRESSION; SYSTEM; PET; CRISPR;
D O I
10.1016/j.dmpk.2022.100450
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Lipid nanoparticles (LNPs) are becoming popular as a means of delivering therapeutics, including those based on nucleic acids and mRNA. The mRNA-based coronavirus disease 2019 vaccines are perfect ex-amples to highlight the role played by drug delivery systems in advancing human health. The funda-mentals of LNPs for the delivery of nucleic acid-and mRNA-based therapeutics, are well established. Thus, future research on LNPs will focus on addressing the following: expanding the scope of drug de-livery to different constituents of the human body, expanding the number of diseases that can be tar -geted, and studying the change in the pharmacokinetics of LNPs under physiological and pathological conditions. This review article provides an overview of recent advances aimed at expanding the appli-cation of LNPs, focusing on the pharmacokinetics and advantages of LNPs. In addition, analytical tech-niques, library construction and screening, rational design, active targeting, and applicability to gene editing therapy have also been discussed.
引用
收藏
页数:13
相关论文
共 144 条
[1]   RNA targeting with CRISPR-Cas13 [J].
Abudayyeh, Omar O. ;
Gootenberg, Jonathan S. ;
Essletzbichler, Patrick ;
Han, Shuo ;
Joung, Julia ;
Belanto, Joseph J. ;
Verdine, Vanessa ;
Cox, David B. T. ;
Kellner, Max J. ;
Regev, Aviv ;
Lander, Eric S. ;
Voytas, Daniel F. ;
Ting, Alice Y. ;
Zhang, Feng .
NATURE, 2017, 550 (7675) :280-+
[2]   C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector [J].
Abudayyeh, Omar O. ;
Gootenberg, Jonathan S. ;
Konermann, Silvana ;
Joung, Julia ;
Slaymaker, Ian M. ;
Cox, David B. T. ;
Shmakov, Sergey ;
Makarova, Kira S. ;
Semenova, Ekaterina ;
Minakhin, Leonid ;
Severinov, Konstantin ;
Regev, Aviv ;
Lander, Eric S. ;
Koonin, Eugene V. ;
Zhang, Feng .
SCIENCE, 2016, 353 (6299)
[3]   The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs [J].
Akinc, Akin ;
Maier, Martin A. ;
Manoharan, Muthiah ;
Fitzgerald, Kevin ;
Jayaraman, Muthusamy ;
Barros, Scott ;
Ansell, Steven ;
Du, Xinyao ;
Hope, Michael J. ;
Madden, Thomas D. ;
Mui, Barbara L. ;
Semple, Sean C. ;
Tam, Ying K. ;
Ciufolini, Marco ;
Witzigmann, Dominik ;
Kulkarni, Jayesh A. ;
van der Meel, Roy ;
Cullis, Pieter R. .
NATURE NANOTECHNOLOGY, 2019, 14 (12) :1084-1087
[4]   Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms [J].
Akinc, Akin ;
Querbes, William ;
De, Soma ;
Qin, June ;
Frank-Kamenetsky, Maria ;
Jayaprakash, K. Narayanannair ;
Jayaraman, Muthusamy ;
Rajeev, Kallanthottathil G. ;
Cantley, William L. ;
Dorkin, J. Robert ;
Butler, James S. ;
Qin, LiuLiang ;
Racie, Timothy ;
Sprague, Andrew ;
Fava, Eugenio ;
Zeigerer, Anja ;
Hope, Michael J. ;
Zerial, Marino ;
Sah, Dinah W. Y. ;
Fitzgerald, Kevin ;
Tracy, Mark A. ;
Manoharan, Muthiah ;
Koteliansky, Victor ;
de Fougerolles, Antonin ;
Maier, Martin A. .
MOLECULAR THERAPY, 2010, 18 (07) :1357-1364
[5]   A Neutral Envelope-Type Nanoparticle Containing pH-Responsive and SS-Cleavable Lipid-Like Material as a Carrier for Plasmid DNA [J].
Akita, Hidetaka ;
Ishiba, Ryohei ;
Hatakeyama, Hiroto ;
Tanaka, Hiroki ;
Sato, Yusuke ;
Tange, Kota ;
Arai, Masaya ;
Kubo, Kazuhiro ;
Harashima, Hideyoshi .
ADVANCED HEALTHCARE MATERIALS, 2013, 2 (08) :1120-1125
[6]   Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles [J].
Arteta, Marianna Yanez ;
Kjellman, Tomas ;
Bartesaghi, Stefano ;
Wallin, Simonetta ;
Wu, Xiaoqiu ;
Kvist, Alexander J. ;
Dabkowska, Aleksandra ;
Szekely, Noemi ;
Radulescu, Aurel ;
Bergenholtz, Johan ;
Lindfors, Lennart .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (15) :E3351-E3360
[7]   Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA [J].
Belliveau, Nathan M. ;
Huft, Jens ;
Lin, Paulo J. C. ;
Chen, Sam ;
Leung, Alex K. K. ;
Leaver, Timothy J. ;
Wild, Andre W. ;
Lee, Justin B. ;
Taylor, Robert J. ;
Tam, Ying K. ;
Hansen, Carl L. ;
Cullis, Pieter R. .
MOLECULAR THERAPY-NUCLEIC ACIDS, 2012, 1 :e37
[8]   Positron emission tomography microdosing:: a new concept with application in tracer and early clinical drug development [J].
Bergström, M ;
Grahnén, A ;
Långström, B .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 59 (5-6) :357-366
[9]   ALPHA-4-BETA-7-INTEGRIN MEDIATES LYMPHOCYTE BINDING TO THE MUCOSAL VASCULAR ADDRESSIN MADCAM-1 [J].
BERLIN, C ;
BERG, EL ;
BRISKIN, MJ ;
ANDREW, DP ;
KILSHAW, PJ ;
HOLZMANN, B ;
WEISSMAN, IL ;
HAMANN, A ;
BUTCHER, EC .
CELL, 1993, 74 (01) :185-195
[10]   Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents [J].
Blanchard, Emmeline L. ;
Vanover, Daryll ;
Bawage, Swapnil Subhash ;
Tiwari, Pooja Munnilal ;
Rotolo, Laura ;
Beyersdorf, Jared ;
Peck, Hannah E. ;
Bruno, Nicholas C. ;
Hincapie, Robert ;
Michel, Frank ;
Murray, Jackelyn ;
Sadhwani, Heena ;
Vanderheyden, Bob ;
Finn, M. G. ;
Brinton, Margo A. ;
Lafontaine, Eric R. ;
Hogan, Robert J. ;
Zurla, Chiara ;
Santangelo, Philip J. .
NATURE BIOTECHNOLOGY, 2021, 39 (06) :717-726